AtaiBeckley: BPL-003 Phase 3 Momentum Keeps Me Bullish

AtaiBeckley Inc. ( ATAI ) is a clinical-stage company that develops psychedelic therapies for treatment-resistant depression (TRD) and social anxiety disorder (SAD). It was formed after a combination of Atai Life Sciences and Beckley Psytech. ATAI's pipeline includes BPL-003 for TRD, whichMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Ath ...